|
Market Closed -
Australian S.E.
02:10:33 2026-07-10 am EDT
|
5-day change
|
1st Jan Change
|
|
121.62 AUD
|
-1.67%
|
 |
-2.67%
|
-53.34%
|
|
May. 04 |
From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis
|
RE
| |
Apr. 30 |
Cochlear Needs to Keep Promoting Implants as Volume Delays Not Structural, Says Jefferies, Shares Up 4%
|
MT
| |
Apr. 23 |
Jarden Adjusts Cochlear's Price Target to AU$169 from AU$224, Keeps at Neutral
|
MT
| |
Apr. 22 |
Cochlear Limited, Q3 2026 Sales/ Trading Statement Call, Apr 22, 2026
| | |
Apr. 22 |
Australian shares close at two-week low, Cochlear crashes 41%
|
RE
| |
Apr. 22 |
Cochlear's Guidance Cut 'Far Worse Than Anticipated,' Multiple Also at Risk, Jarden Says
|
MT
| |
Apr. 21 |
Cochlear reduces underlying net profit guidance for FY26 to A$290-330 million
|
RE
| |
Apr. 21 |
Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact
|
RE
| |
Apr. 21 |
Cochlear Says Trading Conditions for Implants Weaker Than Expected Since January; Shares Hit 10-Year Low
|
MT
| |
Apr. 21 |
Cochlear cuts fiscal 2026 earnings outlook on Middle East-led demand uncertainty
|
RE
| |
Apr. 09 |
Cochlear Says Bank of New York Mellon Becomes Substantial Holder
|
MT
| |
Mar. 18 |
Cochlear : Hearing Loss Screening Fact Sheet
|
PU
| |
Mar. 17 |
Cochlear Poised for Medium-Term Growth on Nexa Launch, Jefferies Says
|
MT
| |
Feb. 12 |
Cochlear shares plunge, flags annual earnings at lower end of outlook
|
RE
| |
Feb. 12 |
Cochlear Limited, H1 2026 Earnings Call, Feb 13, 2026
| | |
Feb. 12 |
Cochlear flags annual earnings at lower end of outlook, shares tank 16%
|
RE
| |
Feb. 12 |
Cochlear Fiscal H1 Earnings Slip, Total Revenue Flat; Shares Hit Over Three-Year Low
|
MT
| |
Feb. 12 |
Cochlear Fiscal H1 Earnings Slip, Total Revenue Flat
|
MT
| |
Feb. 12 |
Cochlear Posts Fiscal H1 Underlying EPS of AU$2.978, Sales Revenue of AU$1.18 Billion Vs FactSet Estimate of AU$1.21 Billion
|
MT
| |
Feb. 12 |
Cochlear posts H1 adjusted net income A$194.8 million
|
RE
| |
Feb. 12 |
Cochlear Limited Announces an Interim Franked Ordinary Dividend for the Six Months Ended December 31, 2025, Payable on 13 April 2026
|
CI
| |
Feb. 12 |
Cochlear Limited Reports Earnings Results for the Half Year Ended December 31, 2025
|
CI
| |
Feb. 02 |
Cochlear Expected to Grow Market Share With Implant, Processor Products, Jefferies Says
|
MT
| |
Jan. 08 |
Cochlear Announces Availability of Nucleus Nexa System to Us Military Veterans
|
CI
| |
25-10-22 |
Cochlear Reaffirms Fiscal 2026 Underlying Profit Guidance
|
MT
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions | 
Choose MarketScreener 
